DLL3 and neuroendocrine carcinoma: To address these questions, we analysed DLL3 expression in a large multicentric cohort of 1294 NET and NEC (301 pulmonary, 993 extrapulmonary), along with 67 matched NEN metastases and 479 non-neuroendocrine carcinomas.